Clinical Trial

Immune Homeostasis in Sepsis and Septic Shock

Study acronym: IMHOTEP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2024 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Detailed description of immune response and its dynamics in sepsis and septic shock patiens by means of transcriptomics, flow-cytometry and cytokine analysis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-06-24; most recent amendment 2024-08-20.
Trial Details
NCT Number NCT04448951
Lead Sponsor Charles University, Czech Republic
Conditions Sepsis, Immunologic Paralysis, Immunologic Suppression, Immune Deficiency
Enrollment 200 participants
Start Date 2020-09-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-21